Patient Preferences in the Management of Wet Age-Related Macular Degeneration: A Conjoint Analysis
Theme: Patient Involvement
Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries
Fundamentals of the Diagnosis and Management of Inherited Retinal Diseases
Lived experiences of genetic diagnosis for rare disease patients: a qualitative interview study
Expert Consensus on Geographic Atrophy in the EU: A Call for Urgent Policy Action
Therapies for Inherited Retinal Dystrophies: What is Enough?
The burden of X-linked retinitis pigmentosa (XLRP) on patientexperience and patient-reported outcomes (PROs): findingsfrom the EXPLORE XLRP-2 study
The Impact of Inherited Retinal Diseases in the United States of America (US) and Canada from a Cost-of-Illness Perspective
The socioeconomic impact of inherited retinal dystrophies (IRDs) in Canada
The socioeconomic impact of inherited retinal dystrophies (IRDs) in the United Kingdom
The socioeconomic impact of inherited retinal dystrophies (IRDs) in the Republic of Ireland
Valuing patients’ high unmet need to drive innovative therapies for inherited retinal degenerations: insights from the RIWC 2024 workshop on value
-
close